Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Prevalence of Tuberculosis in a Prison in Tehran by Active Case Finding

Author(s): Behnam Farhoudi, SeyedAhmad SeyedAlinaghi*, Mostafa Hosseini, Fatemeh Golsoorat Pahlaviani, Mona Mohammadi Firouzeh, Mohammad Shahbazi and Minoo Mohraz

Volume 19, Issue 2, 2019

Page: [167 - 170] Pages: 4

DOI: 10.2174/1871526518666180507122425

Price: $65

Abstract

Background: Tuberculosis [TB] is one of the most important infectious diseases among prisoners. TB Screening plays an important role in prevention among prisoners and their visitors, also better caring of the patients. Active case finding is one of screening methods that is relatively an easy one to find TB suspected prisoners. Therefore, we aimed to assess the prevalence of TB in male prisoners in Tehran, Iran.

Methods: This study was conducted among male prisoners in Great Tehran Prison to screen and diagnose TB patients from October 2013 to May 2014. We used active case finding [ACF] as a screening method to find TB suspected prisoners in which healthcare staff explained TB symptoms for prisoners and individuals with those symptoms referred to the clinic for further work up (sputum sample tests).

Results: In total of 6900 prisoners, 448 (6.5%) prisoners were TB suspected by ACF and only nine patients were diagnosed with tuberculosis, indicating the prevalence of 0.13%.

Conclusion: The relatively low TB prevalence within prisoners besides considering likely common symptoms in ACF may result in many false positive cases during screening (6.5% vs. 0.13%). But, ACF is more fast, easy and affordable method to find TB suspected prisoners. Also, during this active method, prisoners are trained about TB symptoms so, it has a more prolonged effect towards screening goals.

Keywords: Tuberculosis, prevalence, symptoms, prison, active case finding, sensitivity.

Graphical Abstract

[1]
Biadglegne, F.; Rodloff, A.C.; Sack, U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol. Infect., 2015, 143(5), 887-900.
[2]
The Health Crisis Of Tuberculosis In Prisons Extends Beyond The Prison Walls. PLoS Med., 2010, 7e1000383
[3]
Baussano, I.; Williams, B.G.; Nunn, P.; Beggiato, M.; Fedeli, U.; Scano, F. Tuberculosis incidence in prisons: a systematic review. PLoS Med., 2010, 7(12)e1000381
[4]
Tayeri, K. HIV/TB Co-Infection.Current Studies in HIV Research; SeyedAlinaghi, S.A., 2016, Vol;2, 106-111.
[5]
Sretrirutchai, S.; Silapapojakul, K.; Palittapongarnpim, P.; Phongdara, A.; Vuddhakul, V. Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility. Int. J. Tuberc. Lung Dis., 2002, 6(3), 208-214.
[6]
Sanchez, A.; Gerhardt, G.; Natal, S.; Capone, D.; Espinola, A.; Costa, W.; Pires, J.; Barreto, A.; Biondi, E.; Larouzé, B. Prevalence of pulmonary tuberculosis and comparative evaluation of screening strategies in a Brazilian prison. Int. J. Tuberc. Lung Dis., 2005, 9(6), 633-639.
[7]
Telisinghe, L.; Fielding, K.L.; Malden, J.L.; Hanifa, Y.; Churchyard, G.J.; Grant, A.D.; Charalambous, S. High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PLoS One, 2014, 9(1)e87262
[8]
Henostroza, G.; Topp, S.M.; Hatwiinda, S.; Maggard, K.R.; Phiri, W.; Harris, J.B.; Krüüner, A.; Kapata, N.; Ayles, H.; Chileshe, C.; Reid, S.E. The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a large Zambian prison: a public health alert. PLoS One, 2013, 8(8)e67338
[9]
Melese, A.; Demelash, H. The prevalence of tuberculosis among prisoners in Ethiopia: a systematic review and meta-analysis of published studies. Arch. Public Health, 2017, 75, 37.
[10]
Telisinghe, L.; Charalambous, S.; Topp, S.M.; Herce, M.E.; Hoffmann, C.J.; Barron, P.; Schouten, E.J.; Jahn, A.; Zachariah, R.; Harries, A.D.; Beyrer, C.; Amon, J.J. HIV and tuberculosis in prisons in sub-Saharan Africa. Lancet, 2016, 388(10050), 1215-1227.
[11]
Dolan, K.; Wirtz, A.L.; Moazen, B.; Ndeffo-Mbah, M.; Galvani, A.; Kinner, S.A.; Courtney, R.; McKee, M.; Amon, J.J.; Maher, L.; Hellard, M.; Beyrer, C.; Altice, F.L. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet, 2016, 388(10049), 1089-1102.
[12]
Edge, C.L.; King, E.J.; Dolan, K.; McKee, M. Prisoners co-infected with tuberculosis and HIV: a systematic review. J. Int. AIDS Soc., 2016, 19(1), 20960.
[13]
Aerts, A.; Hauer, B.; Wanlin, M.; Veen, J. Tuberculosis and tuberculosis control in European prisons. Int. J. Tuberc. Lung Dis., 2006, 10(11), 1215-1223.
[14]
Chan, P.C.; Yang, C.H.; Chang, L.Y.; Wang, K.F.; Kuo, Y.C.; Lin, C.J.; Lee, S.W.; Hsueh, P.R.; Fang, C.T.; Huang, L.M. Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates. Thorax, 2013, 68(3), 263-268.
[15]
Corbett, E.L.; Zezai, A.; Cheung, Y.B.; Bandason, T.; Dauya, E.; Munyati, S.S.; Butterworth, A.E.; Rusikaniko, S.; Churchyard, G.J.; Mungofa, S.; Hayes, R.J.; Mason, P.R. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull. World Health Organ., 2010, 88(1), 13-21.
[16]
www.tbcontrollers.org/docs/TBDrugsAnd BiologicsShortages/Delaware_TB_Symptom_Screening_Questionnaire.pdf
[17]
Shayo, G.A.; Minja, L.T.; Egwaga, S.; Bakari, M.; Mugusi, F.M. Symptom-based screening tool in ruling out active tuberculosis among HIV-infected patients eligible for isoniazid preventive therapy in Tanzania. Trop. Med. Int. Health, 2014, 19(6), 726-733.
[18]
Kim, L.; Heilig, C.M.; McCarthy, K.D.; Phanuphak, N.; Chheng, P.; Kanara, N.; Quy, H.T.; Sar, B.; Cain, K.P.; Varma, J.K. Symptom screen for identification of highly infectious tuberculosis in people living with HIV in Southeast Asia. J. Acquir. Immune Defic. Syndr., 2012, 60(5), 519-524.
[19]
Stop, T.B. Sensitivity, specificity and predictive values of symptoms to detect tuberculosis in the ZAMSTAR community based prevalence studies., http://www.stoptb.org/wg/tb_hiv/assets/documents/ MeetingDocs14/PGFausett_CROI_ZAMSTAR.pdf
[20]
Davies, P.D.O.; Pai, M. The diagnosis and misdiagnosis of tuberculosis. Int. J. Tuberc. Lung Dis., 2008, 12(11), 1226-1234.
[21]
World Health Organization. Specialized Information Services: publications, iris., 2013.http://apps.who.int/iris/bitstream/10665/ 112472/1/9789241506335_eng.pdf
[22]
Vinkeles Melchers, N.V.; van Elsland, S.L.; Lange, J.M.; Borgdorff, M.W.; van den Hombergh, J. State of affairs of tuberculosis in prison facilities: a systematic review of screening practices and recommendations for best TB control. PLoS One, 2013, 8(1)e53644
[23]
Farhoudi, B. SeyedAlinaghi, S.; Tabarsi, P.; Mohraz, M.; Golrokhy, R.; Farnia, M.; Shahbazi, M.; Alasvand, R.; Ebrahimi, B.; Esfehani, J.; Tashakoriyan, M. Revision and Implementation of “Clinical Guideline for Tuberculosis and HIV in Prisons”, Great Tehran Prison, Iran. Infect. Disord. Drug Targets, 2018, 18(1), 72-80.
[24]
Farhoudi, B. SeyedAlinaghi S, Mohraz M, Hosseini M, Farnia, M. Tuberculosis, hepatitis C and hepatitis B co-infections in patients with HIV in the Great Tehran Prison, Iran. Asian Pac. J. Trop. Dis., 2016, 6(1), 82-83.
[25]
SeyedAlinaghi SA, Farhoudi B, Najafi Z, Jafari S, Shahbazi M. Comparing Tuberculosis Incidence in a Prison with the Society, Tehran, Iran. Arch Clin Infect Dis. Online ahead of Print; In Press(In Press):e60247..
[http://dx.doi.org/doi: 10.5812/archcid.60247.]

Rights & Permissions Print Cite
Article Metrics
25
3
1
1
© 2024 Bentham Science Publishers | Privacy Policy